Double maintains 2 strategies that include AXSM - Axsome Therapeutics, Inc.
Current Value
$103.731 Year Return
Current Value
$103.731 Year Return
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
XPH | 46.18% | $141.28M | 0.35% |
PBE | 41.77% | $224.25M | 0.58% |
XBI | 40.61% | $5.19B | 0.35% |
IBB | 40.52% | $5.41B | 0.45% |
BBH | 38.63% | $340.78M | 0.35% |
IHE | 37.39% | $563.21M | 0.39% |
FBT | 36.82% | $1.05B | 0.56% |
VHT | 36.17% | $15.32B | 0.09% |
FHLC | 36.06% | $2.46B | 0.084% |
INCM | 35.83% | $625.49M | 0.38% |
PINK | 35.64% | $133.30M | 0.5% |
PID | 35.30% | $850.33M | 0.53% |
IXJ | 35.23% | $3.87B | 0.41% |
HYXF | 35.10% | $174.67M | 0.35% |
QUS | 35.05% | $1.51B | 0.15% |
PTH | 35.03% | $99.77M | 0.6% |
SCYB | 35.00% | $1.08B | 0.03% |
SHYG | 34.85% | $6.19B | 0.3% |
IYH | 34.81% | $2.81B | 0.39% |
HYLB | 34.68% | $3.84B | 0.05% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
VSA | -11.43% | $6.72M | -45.11% | 0.00% |
AIFU | -9.09% | $191.32M | +5.63% | 0.00% |
WBA | -8.10% | $9.72B | -29.53% | 4.47% |
HEES | -8.05% | $3.48B | +99.62% | 1.17% |
SHLS | -7.63% | $763.99M | -40.03% | 0.00% |
ZCMD | -6.68% | $29.42M | -14.96% | 0.00% |
CNC | -5.26% | $28.90B | -24.91% | 0.00% |
LITB | -5.25% | $25.74M | -66.23% | 0.00% |
PLRX | -5.05% | $82.26M | -90.00% | 0.00% |
FSLR | -5.01% | $16.77B | -37.41% | 0.00% |
CYCN | -4.71% | $10.43M | +9.80% | 0.00% |
EVGO | -4.56% | $495.08M | +75.71% | 0.00% |
CMTL | -4.09% | $64.27M | -0.91% | 0.00% |
CME | -3.73% | $101.62B | +32.97% | 3.72% |
VHC | -3.51% | $33.82M | +73.48% | 0.00% |
K | -3.05% | $28.48B | +33.83% | 2.76% |
PLUG | -2.75% | $862.56M | -73.99% | 0.00% |
SYPR | -2.65% | $36.77M | +4.58% | 0.00% |
SRRK | -2.39% | $2.89B | +182.30% | 0.00% |
UFI | -2.04% | $93.09M | -22.24% | 0.00% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
ACHV | 38.62% | $103.01M | -45.10% | 0.00% |
SWTX | 38.31% | $3.49B | +8.08% | 0.00% |
CRNX | 37.68% | $2.82B | -38.08% | 0.00% |
COGT | 34.75% | $563.59M | -33.91% | 0.00% |
XENE | 34.66% | $2.34B | -20.72% | 0.00% |
IONS | 34.25% | $5.29B | -12.47% | 0.00% |
SDGR | 33.52% | $1.56B | -2.75% | 0.00% |
ALT | 33.41% | $467.99M | -21.92% | 0.00% |
ALIT | 33.16% | $2.91B | -33.89% | 0.74% |
BPMC | 32.62% | $6.48B | -2.00% | 0.00% |
CLF | 32.41% | $3.45B | -58.81% | 0.00% |
MNDY | 32.18% | $14.71B | +18.38% | 0.00% |
THRY | 32.08% | $585.65M | -34.46% | 0.00% |
DNLI | 31.97% | $1.98B | -29.08% | 0.00% |
LIN | 31.77% | $216.06B | +6.18% | 1.25% |
HON | 31.68% | $143.72B | +12.16% | 2.02% |
ARWR | 31.44% | $2.13B | -37.62% | 0.00% |
ICLR | 31.24% | $10.26B | -60.32% | 0.00% |
DD | 31.20% | $28.46B | -13.83% | 2.32% |
ABEO | 30.85% | $336.61M | +57.79% | 0.00% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
FENG | -0.04% | $11.99M | +21.31% | 0.00% |
JRVR | 0.04% | $252.87M | -28.16% | 2.21% |
BEEM | 0.22% | $26.22M | -72.97% | 0.00% |
IP | 0.23% | $25.67B | +10.12% | 3.90% |
FRPT | 0.26% | $4.14B | -33.77% | 0.00% |
NEUE | -0.31% | $61.42M | +15.24% | 0.00% |
NEOG | 0.33% | $1.34B | -53.46% | 0.00% |
DADA | 0.34% | $546.84M | +17.22% | 0.00% |
STG | 0.36% | $26.51M | -45.13% | 0.00% |
RUM | 0.38% | $3.13B | +32.00% | 0.00% |
AMCX | -0.39% | $281.69M | -62.00% | 0.00% |
LCID | 0.43% | $8.11B | -2.21% | 0.00% |
EPC | 0.43% | $1.27B | -31.82% | 2.23% |
UUU | 0.53% | $5.44M | +55.63% | 0.00% |
QXO | -0.56% | $8.79B | -83.17% | 0.00% |
PRA | 0.71% | $1.18B | +58.96% | 0.00% |
ANF | -0.75% | $3.66B | -47.38% | 0.00% |
PRGS | -0.85% | $2.64B | +21.15% | 0.58% |
MNSO | -0.86% | $6.85B | -0.72% | 3.31% |
DLNG | 0.94% | $128.25M | -6.91% | 4.08% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
XONE | -0.11% | $610.73M | 0.03% |
BSMW | -0.23% | $102.28M | 0.18% |
BSCP | 0.24% | $3.44B | 0.1% |
SPTS | 0.26% | $5.74B | 0.03% |
SMB | -0.58% | $269.48M | 0.07% |
UUP | -0.59% | $277.56M | 0.77% |
JMST | -0.81% | $3.71B | 0.18% |
KMLM | -0.88% | $190.16M | 0.9% |
TPMN | -0.92% | $30.83M | 0.65% |
UDN | 1.21% | $138.93M | 0.78% |
GSST | -1.57% | $878.39M | 0.16% |
SHYM | -1.62% | $323.08M | 0.35% |
SPSK | 1.68% | $307.69M | 0.5% |
IBTG | 2.01% | $1.90B | 0.07% |
CGSM | 2.02% | $668.86M | 0.25% |
TBLL | 2.18% | $2.31B | 0.08% |
FXE | -2.23% | $520.10M | 0.4% |
CMBS | 2.33% | $431.43M | 0.25% |
SMMU | 2.40% | $830.50M | 0.35% |
TFLO | 2.45% | $7.03B | 0.15% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
VIXY | -25.96% | $126.83M | 0.85% |
TAIL | -24.59% | $118.71M | 0.59% |
BTAL | -20.90% | $360.65M | 1.43% |
GBIL | -14.61% | $6.06B | 0.12% |
ULST | -10.22% | $638.58M | 0.2% |
CLIP | -9.09% | $1.51B | 0.07% |
XHLF | -8.44% | $1.46B | 0.03% |
SHV | -7.38% | $20.82B | 0.15% |
XBIL | -7.07% | $778.49M | 0.15% |
BOXX | -7.06% | $6.29B | 0.19% |
BIL | -6.91% | $45.04B | 0.1356% |
BILS | -6.30% | $3.92B | 0.1356% |
SGOV | -6.17% | $46.65B | 0.09% |
USFR | -5.02% | $18.91B | 0.15% |
IVOL | -4.33% | $355.73M | 1.02% |
USDU | -4.05% | $169.80M | 0.5% |
BILZ | -3.31% | $871.57M | 0.14% |
IBDQ | -3.23% | $3.07B | 0.1% |
FXY | -3.21% | $857.57M | 0.4% |
FXE | -2.23% | $520.10M | 0.4% |
SeekingAlpha
The US equity market receded in the first quarter, as US tariff plans impacted outlooks for corporate spending and economic growth. Read more here.
SeekingAlpha
In the first quarter, the Lazard US Equity Concentrated Portfolio underperformed its benchmark, the S&P 500 Index. Read more here.
Yahoo
Previous term loan facility retired NEW YORK, May 13, 2025 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company leading a new era in the treatment of central nervous system (CNS) disorders, today announced that it has entered into a $570 million term loan and revolving credit facility with funds managed by Blackstone Life Sciences and Blackstone Credit & Insurance (“Blackstone”). Concurrent with this new facility, Axsome has retired its previous term loan wit
Finnhub
Axsome Therapeutics Inc: * AXSOME THERAPEUTICS ENTERS $570 MILLION TERM LOAN ANDREVOLVINGCREDIT FACILITY WITH BLACKSTONE * AXSOME THERAPEUTICS: RETIRED ITS PREVIOUS TERM...
Yahoo
Vertex Pharmaceuticals is diversifying its already strong lineup of medicines. Axsome Therapeutics has multiple clinical and regulatory catalysts on the way. Two excellent candidates are Vertex Pharmaceuticals (NASDAQ: VRTX) and Axsome Therapeutics (NASDAQ: AXSM).
Yahoo
Axsome Therapeutics is taking off, led by a treatment for major depressive disorder. Iovance Biotherapeutics could transform how solid tumors are treated. Here's why they think Axsome Therapeutics (NASDAQ: AXSM), Iovance Biotherapeutics (NASDAQ: IOVA), and Viking Therapeutics (NASDAQ: VKTX) are monster stocks in the making.